Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs

被引:7
|
作者
Han, Qingyue [1 ]
Sun, Jie [1 ]
Xie, Wenting [1 ]
Bai, Yuman [1 ]
Wang, Shuzhou [1 ]
Huang, Jianjia [1 ]
Zhou, Shuilian [1 ]
Li, Quanwei [1 ]
Zhang, Hui [1 ]
Tang, Zhaoxin [1 ]
机构
[1] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China
基金
国家重点研发计划;
关键词
ANIMAL-MODELS; MELLITUS; INDUCTION; INFUSION; CANINES;
D O I
10.1155/2022/5422287
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Type 1 diabetes mellitus (T1DM) is a chronic disease represented by insulin-causing pancreatic beta-cell disruption and hyperglycemia. Therefore, it is necessary to establish a variety of animal models of diabetes to study the pathogenesis and pathophysiology of it. However, there are few reports on the use of beagle dogs to establish an animal model of type 1 diabetes. This study aimed to explore a simple and feasible modeling method to establish a long-term and stable type 1 diabetes model in beagle dogs. Forty adult beagle dogs were randomly divided into control group and model group. After 24 h of fasting, streptozotocin (20 mg/kg) and alloxan (20 mg/kg) were injected through the cephalic vein. The second intravenous injection was given on the 4th day after the first injection. Insulin release testing was performed on the 7th day after the last intravenous injection. Fasting blood glucose and body weight were recorded monthly. Four months after the last injection, the serum fructosamine content and the ratio of glycated hemoglobin were detected. Then, the pancreatic tissue was harvested for histopathological examination. The results showed that the level of fasting blood glucose of the 16 dogs in the model group was consistently higher than 11.1 mmol/L for 4 consecutive months. Moreover, compared with the control group, the insulin release curve of the model group was flat with no increase. The body weight of the model group was significantly reduced, and the ratios of blood glucose, fructosamine, and glycosylated hemoglobin were significantly higher than those in the control group. Meanwhile, histopathological examination of the pancreas showed that the islet beta cells appeared to have vacuoles or even necrosis. In the model group, pancreatic beta-cells were damaged and insulin release was reduced. These results suggest that the above modeling methods can induce long-term and stable type 1 diabetes models in beagle dogs.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Phensuccinal attenuates the development of multiple low-dose streptozotocin-induced diabetes
    Gorbenko, N
    Poltorack, V
    Gladkih, A
    Ivanova, O
    DIABETOLOGIA, 1998, 41 : A232 - A232
  • [42] COMPLETE PROTECTION FROM LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES IN MICE
    ROSSINI, AA
    WILLIAMS, RM
    APPEL, MC
    LIKE, AA
    NATURE, 1978, 276 (5684) : 182 - 184
  • [43] HISTOPATHOLOGICAL LESIONS IN THE PANCREAS OF A RAT MODEL OF DIABETES INDUCED WITH COMPLETE FREUND ADJUVANT AND LOW-DOSE STREPTOZOTOCIN
    KOHNERT, KD
    FALT, K
    ZIEGLER, B
    ODSELIUS, R
    ZIEGLER, M
    FALKMER, S
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 1990, 95 (01): : 47 - 56
  • [44] Dose-dependent progression of multiple low-dose streptozotocin- induced diabetes in mice
    Bauer, Brandon M.
    Bhattacharya, Supriyo
    Bloom-Saldana, Elizabeth
    Irimia-Dominguez, Jose M.
    Fueger, Patrick T.
    PHYSIOLOGICAL GENOMICS, 2023, 55 (09) : 381 - 391
  • [45] EFFECTS OF DOSE AND TIME IN A LONG-TERM, LOW-DOSE CARCINOGENIC STUDY
    LITTLEFIELD, NA
    FARMER, JH
    GAYLOR, DW
    SHELDON, WG
    JOURNAL OF ENVIRONMENTAL PATHOLOGY AND TOXICOLOGY, 1980, 3 : 17 - 34
  • [46] Endangered Lymphocytes: The Effects of Alloxan and Streptozotocin on Immune Cells in Type 1 Induced Diabetes
    Queiroz, Luiz A. D.
    Assis, Josiane B.
    Guimaraes, Joao P. T.
    Sousa, Emanuella S. A.
    Milhomem, Analia C.
    Sunahara, Karen K. S.
    Sa-Nunes, Anderson
    Martins, Joilson O.
    MEDIATORS OF INFLAMMATION, 2021, 2021
  • [47] Long-term low-dose atorvastatin therapy and prevention of macroangiopathy complications in elderly patients with Type 2 diabetes mellitus
    Batrak, G. A.
    Myasoedova, S. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2010, 9 (03): : 68 - 72
  • [48] TIMP-1 transgenic mice recover from diabetes induced by multiple low-dose streptozotocin
    Jiang, Hongwei
    Zhu, Hanyu
    Chen, Xiangmei
    Peng, Youming
    Wang, Jianzhong
    Liu, Fuyou
    Shi, Suozhu
    Fu, Bo
    Lu, Yang
    Hong, Quan
    Feng, Zhe
    Hou, Kai
    Sun, Xuefeng
    Cai, Guangyan
    Zhang, Xueguang
    Xie, Yuansheng
    DIABETES, 2007, 56 (01) : 49 - 56
  • [49] INTERLEUKIN-1 RECEPTOR ANTAGONIST PREVENTS LOW-DOSE STREPTOZOTOCIN-INDUCED DIABETES IN MICE
    SANDBERG, JO
    ANDERSSON, A
    EIZIRIK, DL
    SANDLER, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (01) : 543 - 548
  • [50] Trained Innate Immunity by Repeated Low-Dose Lipopolysaccharide Injections Displays Long-Term Neuroprotective Effects
    Zhou, Xiao-yan
    Gao, Rong
    Hu, Jian
    Gao, Da-peng
    Liao, Yan-ling
    Yang, Jian-jun
    MEDIATORS OF INFLAMMATION, 2020, 2020